Mode
Text Size
Log in / Sign up
N/A N=65 Randomized Double-blind Treatment

Efficacy Study of Vaginal Mesh for Prolapse

Pelvic Organ Prolapse · Uterine Prolapse · Vaginal Prolapse · Cystocele · Rectocele

Enrolled (actual)
65
Serious AEs
7.7%
Results posted
Oct 2022
Primary outcome: Primary: Number of Participants With Anatomic Cure at 3 Years — 20; 21; 8; 8 Participants — p=<0.05

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
synthetic monofilament polypropylene mesh (Device)
Age
Adult, Older Adult · 21+ yrs
Sex
Female
Sponsor
Medstar Health Research Institute
Primary completion
Aug 2012

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Anatomic Cure at 3 Years
20; 21; 8; 8; 15; 12 <0.05 sig
SECONDARY
Bothersome Dyspareunia
5; 5; 2; 1; 2; 1

Summary

The primary aim of this double-blind, randomized clinical trial (RCT) is to test the hypothesis that the addition of a standardized technique of interpositional synthetic polypropylene mesh placement improves the one-year outcome of vaginal reconstructive surgery for pelvic organ prolapse compared to traditional vaginal reconstructive surgery without mesh.

Eligibility Criteria

Inclusion Criteria

  • Woman > 21 yrs
  • Stage II-IV vaginal prolapse
  • Desires vaginal reconstructive surgery
  • Able to complete study questionnaires and assessments
  • Uterus < 12 weeks size
  • Available for 12 months follow-up

Exclusion Criteria

  • Medical contraindications, e.g. current urinary tract, vaginal or pelvic infection, history of pelvic irradiation, history of lower urinary tract malignancy, chronic steroid use or a compromised immune system.
  • Current intermittent catheterization.
  • Pregnancy or desire for future fertility.
  • Presence of an adnexal mass.
  • Shortened vagina or other known Mullerian anomaly (e.g. uterine didelphys).
  • Other laparoscopic or abdominal/pelvic surgery in the past 3 months.
  • Known neurologic or medical condition affecting bladder function, e.g. Multiple Sclerosis, spinal cord injury.
  • Need for concomitant surgery requiring an abdominal incision.
  • < 12 months post-partum.
  • Non-english speaking
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00475540). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search